g-Xifaxan

Leerink has released three new reports on some Outperform-rated big-name biotech stocks that the firm’s analysts like in coming months. Here’s a look at what the analysts had to say. Gilead Sciences, Inc. (NASDAQ: GILD) Analyst Geoffrey Porges has a positive view toward the stock,...